NeuroAbstract Posters
Ricerca contenuti
No evidence of disease activity including cognitive evaluation (NEDA-3 plus status) in naive pediatric multiple sclerosis patients treated with natalizumab for 2-years: a longitudinal prospective study
Margoni Monica
